Arrowhead Pharmaceuticals Inc (ARWR)
Debt-to-equity ratio
| Sep 30, 2025 | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 466,052 | 185,444 | 271,343 | 398,520 | 408,822 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
September 30, 2025 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $466,052K
= 0.00
Peer comparison
Sep 30, 2025
Company name
Symbol
Debt-to-equity ratio
Arrowhead Pharmaceuticals Inc
ARWR
0.00
Biomarin Pharmaceutical Inc
BMRN
0.00
Regeneron Pharmaceuticals Inc
REGN
0.00